AbCellera Biologics Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ABCL research report →
Companywww.abcellera.com
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs.
- CEO
- Carl Hansen
- IPO
- 2020
- Employees
- 596
- HQ
- Vancouver, BC, CA
Price Chart
Valuation
- Market Cap
- $1.40B
- P/E
- -9.62
- P/S
- 17.62
- P/B
- 1.48
- EV/EBITDA
- -8.35
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 79.07%
- Op Margin
- -267.61%
- Net Margin
- -181.75%
- ROE
- -14.22%
- ROIC
- -13.84%
Growth & Income
- Revenue
- $75.13M · 160.56%
- Net Income
- $-146,412,000 · 10.10%
- EPS
- $-0.49 · 10.91%
- Op Income
- $-217,103,000
- FCF YoY
- 6.89%
Performance & Tape
- 52W High
- $6.51
- 52W Low
- $1.94
- 50D MA
- $3.91
- 200D MA
- $4.14
- Beta
- 1.03
- Avg Volume
- 5.33M
Get TickerSpark's AI analysis on ABCL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 14, 26 | Montalbano John S. | buy | 20,000 |
| Feb 27, 26 | Thermopylae Holdings Ltd. | buy | 38,000 |
| Feb 26, 26 | Thermopylae Holdings Ltd. | buy | 177,457 |
| Feb 27, 26 | Booth Andrew | buy | 42,600 |
| Jan 1, 26 | Booth Andrew | other | 808,898 |
| Jan 1, 26 | Hansen Carl L. G. | other | 2,106,505 |
| Jan 1, 26 | Stimart Tryn | other | 539,265 |
| Jan 1, 26 | Lecault Veronique | other | 539,265 |
| Dec 1, 25 | Quake Stephen | other | 194,932 |
| Nov 10, 25 | Quake Stephen | other | 0 |
Our ABCL Coverage
We haven't published any research on ABCL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ABCL Report →